Defect of the CTLA4-Ig ligands on tumor-infiltrating dendritic cells.
Chaux
P
P
I.N.S.E.R.M., Research Group on Gastrointestinal Tumors, Faculty of Medicine, Dijon, France.
Martin
M S
MS
Martin
F
F
D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000378:metabolism*; D000951:Antigens, Neoplasm; D060908:CTLA-4 Antigen; D003713:Dendritic Cells / Q000276:immunology* / Q000473:pathology; D007108:Immune Tolerance; D018796:Immunoconjugates; D066298:In Vitro Techniques; D008024:Ligands; D008213:Lymphocyte Activation; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000473:pathology; D051381:Rats; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology
D015703:Antigens, CD; D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D060908:CTLA-4 Antigen; D018796:Immunoconjugates; D008024:Ligands; D011993:Recombinant Fusion Proteins; D000069594:Abatacept